Scott D Collins

3PUBLICATIONS
49CO-AUTHORS
Biologically active moleculesCharacterisation of biological macromoleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 03, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells.

Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster

|Feb 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates.

Joshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin

|Jun 09, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer.

Dorin Toader, Shawn P Fessler, Scott D Collins

Pageof 1